HomeCompareSAFE vs MCK

SAFE vs MCK: Dividend Comparison 2026

SAFE yields 5.20% · MCK yields 0.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCK wins by $22.9K in total portfolio value· pulled ahead in Year 5
10 years
SAFE
SAFE
● Live price
5.20%
Share price
$13.62
Annual div
$0.71
5Y div CAGR
-34.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$8.45
Full SAFE calculator →
MCK
MCK
● Live price
0.38%
Share price
$860.19
Annual div
$3.28
5Y div CAGR
66.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$10,761.37
Full MCK calculator →

Portfolio growth — SAFE vs MCK

📍 MCK pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAFEMCK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAFE + MCK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SAFE pays
MCK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAFE
Annual income on $10K today (after 15% tax)
$441.85/yr
After 10yr DRIP, annual income (after tax)
$7.18/yr
MCK
Annual income on $10K today (after 15% tax)
$32.41/yr
After 10yr DRIP, annual income (after tax)
$9,147.16/yr
At 15% tax rate, MCK beats the other by $9,139.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAFE + MCK for your $10,000?

SAFE: 50%MCK: 50%
100% MCK50/50100% SAFE
Portfolio after 10yr
$32.8K
Annual income
$5,384.90/yr
Blended yield
16.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCK right now

SAFE
Analyst Ratings
8
Buy
6
Hold
3
Sell
Consensus: Buy
Price Target
$15.50
+13.8% upside vs current
Range: $14.00 — $17.00
Altman Z
0.7
Piotroski
4/9
MCK
Analyst Ratings
1
Strong
24
Buy
6
Hold
Consensus: Buy
Price Target
$982.38
+14.2% upside vs current
Range: $900.00 — $1,085.00
Altman Z
5.9
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAFE buys
0
MCK buys
0
No recent congressional trades found for SAFE or MCK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAFEMCK
Forward yield5.20%0.38%
Annual dividend / share$0.71$3.28
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-34.3%66.7%
Portfolio after 10y$21.3K$44.3K
Annual income after 10y$8.45$10,761.37
Total dividends collected$1.0K$22.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$15.50$982.38

Year-by-year: SAFE vs MCK ($10,000, DRIP)

YearSAFE PortfolioSAFE Income/yrMCK PortfolioMCK Income/yrGap
1$11,042$341.52$10,764$63.56+$278.00SAFE
2$12,046$231.54$11,624$106.59+$422.00SAFE
3$13,044$155.11$12,617$179.33+$427.00SAFE
4$14,061$103.13$13,803$303.26+$258.00SAFE
5← crossover$15,113$68.26$15,286$516.89$173.00MCK
6$16,216$45.05$17,248$891.81$1.0KMCK
7$17,381$29.68$20,023$1,567.70$2.6KMCK
8$18,617$19.53$24,260$2,835.35$5.6KMCK
9$19,933$12.85$31,310$5,352.05$11.4KMCK
10$21,337$8.45$44,263$10,761.37$22.9KMCK

SAFE vs MCK: Complete Analysis 2026

SAFEStock

Safehold Inc. (NYSE: SAFE) is revolutionizing real estate ownership by providing a new and better way for owners to unlock the value of the land beneath their buildings. Through its modern ground lease capital solution, Safehold helps owners of high quality multifamily, office, industrial, hospitality and mixed-use properties in major markets throughout the United States generate higher returns with less risk. The Company, which is taxed as a real estate investment trust (REIT) and is managed by its largest shareholder, iStar Inc., seeks to deliver safe, growing income and long-term capital appreciation to its shareholders.

Full SAFE Calculator →

MCKHealthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Full MCK Calculator →
📬

Get this SAFE vs MCK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAFE vs SCHDSAFE vs JEPISAFE vs OSAFE vs KOSAFE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.